Improving B-cell lymphoma treatment with immunotherapies and more
Lymphomas are the most common hematological malignancy in the U.S., accounting for an estimated 80,000 new cancer diagnoses and 21,000 deaths each year. These cancers, broadly classified as either Hodgkin lymphomas or non-Hodgkin lymphomas, develop in the lymphatic system. Approximately 85 percent of cases are B-cell lymphomas, meaning they arise in B lymphocytes.
MD Anderson’s B-Cell Lymphoma Moon Shot™ is working toward...
Be Well Baytown celebrates one year of making impact on community health
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...
Lung Cancer Moon Shot team is learning the most from patients
Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United States,...
Next-generation sequencing bolsters breast, prostate and blood cancer research
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance scientific discoveries into the clinic to save patients’ lives. Driving the work of the Moon Shots™ are 10 research platforms that provide unique expertise, technical support and novel infrastructure to the program’s 13 disease-focused initiatives.
One of those platforms is the Cancer Genomics...
Moon Shot update: Gaining ground on hard-to-treat blood cancers
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction of immature...
Ovarian Moon Shot team battles highly recurrent disease
September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than 22,000 women...
Communication skills may help keep research trainees on the academic track
A well-trained research workforce is essential for addressing both current and future health challenges in the U.S. However, according to...
Basic science research could greatly improve cancer prevention efforts
Many are aware of the importance of cancer research for the discovery of new therapies and treatment options, but perhaps less well-known...
An update on the Prostate Cancer Moon Shot's efforts to improve outcomes, save lives
Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the American Cancer...
Pioneering endogenous T-cell therapy for cancer treatments
Immunotherapy, which stimulates the patient’s own immune system to attack cancer, has shown promise in treating a variety of cancer types...
Researcher found a way to analyze the DNA of individual cancer cells
Understanding evolution within cancer cells is a longtime interest for Nicholas Navin, Ph.D., an associate professor of Genetics and Bioinformatics...
Training dermatologists to detect melanoma at its earliest stages
Each May, Skin Cancer Awareness Month serves as a reminder of how individuals can work to lower their risk of skin cancer – the most common...
Improving practice to eliminate high risk and prevent breast cancer
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...